Physical activity, particularly walking, is a common recommendation for people with chronic obstructive pulmonary disease ...

Chronic obstructive pulmonary disease (COPD) remains one of the most significant causes of death and disability worldwide 1,2. While the utility of primary prevention through smoking cessation and ...

Chronic Obstructive Pulmonary Disease (COPD) is a global health concern, primarily linked to cigarette smoking. The potential role of electronic cigarettes (e-cigarettes) in COPD development remains ...

A growing evidence base shows that chronic obstructive pulmonary disease (COPD) is affected by climate and environmental exposures, not only through extreme temperature exposure and air pollution but ...

High temperatures indoors can contribute to respiratory morbidity among chronic obstructive pulmonary disease patients, according to a study in ATS Journals. Researchers examined 69 patients COPD for ...

Health-related quality of life (HRQOL) did not differ significantly between younger and older patients with chronic obstructive pulmonary disease (COPD) suffering from chronic hypercapnic respiratory ...

Pegtarazimod holds promise for effectively treating acute exacerbations of COPD, a major unmet need in COPD treatment.

Cardiovascular diseases and diabetes are some of the most common coexisting conditions in COPD. Shared risk factors and overlapping physiological processes likely contribute to the high rate of ...

Chronic obstructive pulmonary disease (COPD) is a long-term lung condition that causes inflammation and lung damage. Lifestyle changes such as an anti-inflammatory diet and supplements can help manage ...

People living with chronic obstructive pulmonary disease (COPD) typically rely on maintenance inhalers to manage their daily symptoms. They may also take rescue inhalers for sudden breathing ...

“Compared to non-CMR recipients, CMR recipients experienced a considerably higher increase in adherence to COPD medications from 2016 to 2017, and findings with data from more recent years are ...

David Mannino is co-founder and chief medical officer of the COPD Foundation. He's an internal medicine doctor with a specialty in pulmonary, critical care, and sleep medicine at University of ...